General information on the use of medical cannabis for professionals:
↓ PDF

 

Patient information: ↓ PDF (1 page), ↓ PDF (2 pages)

 

Treatment recommendations from/for the practice

SSCM is currently working on therapy recommendations, whereby the following topics will soon be available: MS-related spasticity, fibromyalgia, dementia, tourette- and restless legs syndrome. Further recommendations are planned, such as for pain, oncology/palliative care, psychiatry, epilepsy and movement disorders.

Please contact daniela.eigenmann@cannabis-med.ch if you have an appropriate expertise or clinical experience and are interested in a cooperation. We would appreciate any active collaborative efforts.

See website DE

 

General dosing recommendations: ↓ PDF (in prep.)

 

General side effects, contraindications, interactions: ↓ PDF (in prep.)

 

Medications

Overview of cannabis- and cannabinoid-based pharmaceutical preparations marketed in Switzerland; galenics, dosages, effects, indications, manufacturers, costs:

  • Cannabisextrakt-basierte Präparate: PDF
  • CBD-basierte Präparate: PDF
  • THC-basierte Präparate: PDF


Guidelines Forum Suchtmedizin Ostschweiz, Fosumos